Baird Financial Group
STJ

Baird Financial Group’s St Jude Medical STJ Stock Holding History

Baird Financial Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,123
Closed -$491K – 1273
2016
Q4 		$491K Buy
6,123
+133
+2% +$10.6K ﹤0.01% 926
2016
Q3 		$478K Sell
5,990
-2,675
-31% -$216K ﹤0.01% 950
2016
Q2 		$685K Sell
8,665
-7,353
-46% -$524K 0.01% 848
2016
Q1 		$881K Buy
16,018
+427
+3% +$23.3K 0.01% 756
2015
Q4 		$963K Buy
15,591
+813
+6% +$51.3K 0.01% 716
2015
Q3 		$932K Sell
14,778
-712
-5% -$50.8K 0.01% 722
2015
Q2 		$1.13M Buy
+15,490
New +$1.12M 0.01% 718

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Baird Financial Group's STJ Position: Q1 2017 in Review

Baird Financial Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,123 shares — an estimated $491K sold.

Baird Financial Group first reported a position in STJ in Q2 2015 and held it in 7 quarters. The position peaked at $1.13M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Baird Financial Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Baird Financial Group sold 6,123 St Jude Medical shares in Q1 2017, an estimated $491K.
  • Baird Financial Group first reported a position in St Jude Medical in Q2 2015 and held it in 7 quarters.
  • Baird Financial Group's St Jude Medical position peaked at $1.13M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Baird Financial Group's 13F filing for Q1 2017, filed 9 May 2017.